{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:26:35Z","timestamp":1791134795649,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T00:00:00Z","timestamp":1437436800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00280-015-2819-3","type":"journal-article","created":{"date-parts":[[2015,7,20]],"date-time":"2015-07-20T07:48:57Z","timestamp":1437378537000},"page":"865-871","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Influence of infusion method on gemcitabine pharmacokinetics: a controlled randomized multicenter trial"],"prefix":"10.1007","volume":"76","author":[{"given":"Nicolas","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Pin\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mich\u00e8le","family":"Vasseur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Lemahieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Barth\u00e9l\u00e9my","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hebbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"D\u00e9caudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Odou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,21]]},"reference":[{"key":"2819_CR1","unstructured":"Agence Nationale de Standardisation (1990) Infusion pumps. 32 p (in French)"},{"key":"2819_CR2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s13318-011-0062-9","volume":"36","author":"N Simon","year":"2011","unstructured":"Simon N, D\u00e9caudin B, Lannoy D, Barth\u00e9l\u00e9my C, Lemdani M, Odou P (2011) Mathematical and physical model of gravity-fed infusion outflow: application to soft-bag-packed solutions. Eur J Drug Metab Pharmacokinet 36:197\u2013203","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2819_CR3","first-page":"1090","volume":"36","author":"M Ziser","year":"1979","unstructured":"Ziser M, Feezor M, Skolaut MW (1979) Regulating intravenous fluid flow: controller versus clamps. Am J Hosp Pharm 36:1090\u20131094","journal-title":"Am J Hosp Pharm"},{"key":"2819_CR4","first-page":"374","volume":"7","author":"RA Pleasants","year":"1988","unstructured":"Pleasants RA, Sawyer WT, Williams DM, McKenna WR, Powell JR (1988) Effect of four intravenous infusion methods on tobramycin pharmacokinetics. Clin Pharm 7:374\u2013379","journal-title":"Clin Pharm"},{"key":"2819_CR5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pupt.2010.03.005","volume":"23","author":"N Simon","year":"2010","unstructured":"Simon N, D\u00e9caudin B, Lannoy D, Odou MF, De Broucker M, Barth\u00e9l\u00e9my C, Poret E, Dubreuil L, Odou P (2010) Impact of infusion method on amikacin serum levels in humans. Pulm Pharmacol Ther 23:324\u2013326","journal-title":"Pulm Pharmacol Ther"},{"key":"2819_CR6","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(79)91939-1","volume":"8128","author":"K Falck","year":"1979","unstructured":"Falck K, Gr\u00f6hn P, Sorsa M, Vainio H, Heinonen E, Holsti L (1979) Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 8128:1250\u20131251","journal-title":"Lancet"},{"key":"2819_CR7","unstructured":"National Institute for Occupational Safety and Health (2004) NIOSH alert\u2014preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings. http:\/\/www.cdc.gov\/niosh\/docs\/2004-165\/"},{"key":"2819_CR8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.2146\/ajhp050529","volume":"63","author":"American Society on Health-System Pharmacists","year":"2006","unstructured":"American Society on Health-System Pharmacists (2006) ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 63:1172\u20131193","journal-title":"Am J Health Syst Pharm"},{"key":"2819_CR9","first-page":"27","volume":"13","author":"ISOPP Standards of Practice","year":"2007","unstructured":"ISOPP Standards of Practice (2007) Special devices. J Oncol Pharm Pract 13:27\u201330","journal-title":"J Oncol Pharm Pract"},{"key":"2819_CR10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/001857870303800213","volume":"38","author":"S Spivey","year":"2003","unstructured":"Spivey S, Connor TH (2003) Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system. Hosp Pharm 38:135\u2013139","journal-title":"Hosp Pharm"},{"key":"2819_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/annhyg\/mem067","volume":"52","author":"O Nygren","year":"2008","unstructured":"Nygren O, Olofsson E, Johansson L (2008) Spill and leakage using a drug preparation system based on double-filter technology. Ann Occup Hyg 52:95\u201398","journal-title":"Ann Occup Hyg"},{"key":"2819_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/1078155211416531","volume":"18","author":"T Queruau-Lamerie","year":"2012","unstructured":"Queruau-Lamerie T, Carrez L, D\u00e9caudin B, Bouchoud L, Goossens JF, Barth\u00e9l\u00e9my C, Bonnabry P, Odou P (2012) Multiple-test assessment of devices to protect healthcare workers when administering cytotoxic drugs to patients. J Oncol Pharm Pract 18:191\u2013200","journal-title":"J Oncol Pharm Pract"},{"key":"2819_CR13","first-page":"17","volume":"4","author":"P Odou","year":"2010","unstructured":"Odou P, Lannoy D, D\u00e9caudin B, Simon N (2010) Medical devices for safe handling of cytotoxic drugs. Eur J Oncol Pharm 4:17\u201319","journal-title":"Eur J Oncol Pharm"},{"key":"2819_CR14","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1188\/10.ONF.E370-E376","volume":"37","author":"N Simon","year":"2010","unstructured":"Simon N, D\u00e9caudin B, Lannoy D, Danicourt F, Barth\u00e9l\u00e9my C, Odou P (2010) Technical evaluation of a new sterile medical device to improve anticancer chemotherapy administration. Oncol Nurs Forum 37:370\u2013376","journal-title":"Oncol Nurs Forum"},{"key":"2819_CR15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/NAN.0b013e3182659abd","volume":"35","author":"L Lalande","year":"2012","unstructured":"Lalande L, Galy G, Dussossoy E, Noyel JE, Pivot C (2012) Evaluation of safe infusion devices for antineoplastic administration. J Infus Nurs 35:321\u2013327","journal-title":"J Infus Nurs"},{"key":"2819_CR16","unstructured":"Agence Nationale de S\u00e9curit\u00e9 des M\u00e9dicaments et des produits de sant\u00e9 (2007) Good compounding practices. 81 p (in French). http:\/\/www.ansm.sante.fr"},{"key":"2819_CR17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchromb.2006.03.023","volume":"835","author":"MN Kirstein","year":"2006","unstructured":"Kirstein MN, Hassan I, Guire DE, Weller DR, Dagit JW, Fisher JE, Remmel RP (2006) High-performance liquid chromatographic method for the determination of gemcitabine and 2,2 difluorodeoxyuridine in plasma and tissue culture media. J Chromatogr B 835:136\u2013142","journal-title":"J Chromatogr B"},{"key":"2819_CR18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1991.9.3.491","volume":"9","author":"JL Abbruzzese","year":"1991","unstructured":"Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN (1991) A phase I clinical, plasma, and cellular pharmacology study of gemcitabine. J Clin Oncol 9:491\u2013498","journal-title":"J Clin Oncol"},{"key":"2819_CR19","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1023\/A:1013133415945","volume":"12","author":"S Fogli","year":"2001","unstructured":"Fogli S, Danesi R, De Braud F, De Pas T, Curigliano G, Giovannetti E, Del Tacca M (2001) Drug distribution and pharmacokinetic\/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small cell lung cancer. Ann Oncol 12:1553\u20131559","journal-title":"Ann Oncol"},{"key":"2819_CR20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1631\/jzus.2007.B0307","volume":"8","author":"LR Wang","year":"2007","unstructured":"Wang LR, Liu J, Huang MZ, Xu N (2007) Comparison of pharmacokinetics, efficacy and toxicity profile of gemcitabine using two different administration regimens in Chinese patients with non-small cell lung cancer. J Zheijiang Univ Sci B 8:307\u2013313","journal-title":"J Zheijiang Univ Sci B"},{"key":"2819_CR21","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2125.2007.03040.x","volume":"65","author":"X Jiang","year":"2007","unstructured":"Jiang X, Galettis P, Links M, Mitchell PL, McLachlan AJ (2007) Population pharmacokinetics of gemcitabine and its metabolite in patients with cancer: effect of oxaliplatin and infusion rate. Br J Clin Pharmacol 65:326\u2013333","journal-title":"Br J Clin Pharmacol"},{"key":"2819_CR22","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ab.2004.05.059","volume":"332","author":"B Yilmaz","year":"2004","unstructured":"Yilmaz B, Kadioglu YY, Aksoy Y (2004) Investigation of the pharmacokinetics of gemcitabine and 2\u2032,2\u2032-difluorodeoxyuridine in human plasma by liquid chromatography. Anal Biochem 332:234\u2013237","journal-title":"Anal Biochem"},{"key":"2819_CR23","doi-asserted-by":"crossref","first-page":"v142","DOI":"10.1093\/annonc\/mdj970","volume":"17","author":"L Cattel","year":"2006","unstructured":"Cattel L, Airoldi M, Delprino L, Passera R, Milla M, Pedani F (2006) Pharmacokinetic evaluation of gemcitabine and 2\u2032,2\u2032-difluorodeoxycytidine-5\u2032-triphosphate after prolonged infusion in patients affected by different solid tumors. Ann Oncol 17:v142\u2013v147","journal-title":"Ann Oncol"},{"key":"2819_CR24","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1200\/JCO.2007.10.7078","volume":"25","author":"P Grimison","year":"2007","unstructured":"Grimison P, Galettis P, Manners S, Jelinek M, Metharom E, de Souza PL, Liauw W, Links M (2007) Randomized crossover study evaluating the effect of gemcitabine infusion dose rate: evidence of auto-induction of gemcitabine accumulation. J Clin Oncol 25:5704\u20135709","journal-title":"J Clin Oncol"},{"key":"2819_CR25","first-page":"136","volume":"13","author":"S Allerheiligen","year":"1994","unstructured":"Allerheiligen S, Johnson R, Hatcher B (1994) Gemcitabine pharmacokinetics are influenced by gender body surface area and duration of infusion. Proc Am Soc Clin Oncol 13:136","journal-title":"Proc Am Soc Clin Oncol"},{"key":"2819_CR26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2006.06.7405","volume":"25","author":"E Sugiyama","year":"2007","unstructured":"Sugiyama E, Kaniwa S, Kim SR, Kikura-Hanajiri R, Hasegawa R, Maekawa K, Saito Y, Ozawa S, Sawada JI, Kamatani N, Furuse J, Ishii H, Yoshida T, Ueno H, Okusaka T, Saijo N (2007) Pharmacokinetics of gemcitabine in Japanese cancer patients: the impact of a cytidine deaminase polymorphism. J Clin Oncol 25:32\u201342","journal-title":"J Clin Oncol"},{"key":"2819_CR27","unstructured":"Maury E, Galbois A, Ait-Oufella H, Baudel JL, Poirier JM, Ricard JD, Buidet B, Offenstadt G (2010) Influence du circuit de perfusion sur le pic s\u00e9rique d\u2019aminosides. In Proceedings of the Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise. http:\/\/www.srlf.org\/data\/ModuleMiseEnLigne\/Generation\/Html\/Web\/evenements\/6\/programmes\/20\/resumes\/3890.html"},{"key":"2819_CR28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(77)91558-6","volume":"8049","author":"T Furber","year":"1977","unstructured":"Furber T, Scobie S, Hambleton R (1977) How much intravenous fluid does the patient get? Lancet 8049:1173\u20131174","journal-title":"Lancet"},{"key":"2819_CR29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1109\/TBME.1983.325183","volume":"30","author":"BK Philip","year":"1983","unstructured":"Philip BK, Philip JH (1983) Characterization of flow in intravenous infusion systems. IEEE Trans Biomed Eng BME 30:702\u2013707","journal-title":"IEEE Trans Biomed Eng BME"},{"key":"2819_CR30","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1109\/TBME.1986.325743","volume":"33","author":"BK Philip","year":"1986","unstructured":"Philip BK, Philip JH (1986) Characterization of flow in intravenous catheters. IEEE Trans Biomed Eng BME 33:529\u2013531","journal-title":"IEEE Trans Biomed Eng BME"},{"key":"2819_CR31","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archsurg.1971.01350050096027","volume":"102","author":"E Fonkalsrud","year":"1971","unstructured":"Fonkalsrud E, Carpenter K, Adelberg M (1971) A new even-flow intravenous infusion clamp. Arch Surg 102:530\u2013531","journal-title":"Arch Surg"},{"key":"2819_CR32","first-page":"367","volume":"7","author":"RA Pleasants","year":"1988","unstructured":"Pleasants RA, Sawyer WT, Williams DM, McKenna WR, Brown JM, Powell JR (1988) Accuracy of tobramycin delivery by four i.v. infusion methods. Clin Pharm 7:367\u2013373","journal-title":"Clin Pharm"},{"key":"2819_CR33","first-page":"2239","volume":"43","author":"M Nahata","year":"1986","unstructured":"Nahata M, Durrell D, Miller D (1986) Accuracy of tobramycin delivery with a controller and a volumetric chamber or syringe. Am J Hosp Pharm 43:2239\u20132241","journal-title":"Am J Hosp Pharm"},{"key":"2819_CR34","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1200\/JCO.2008.20.9007","volume":"27","author":"E Poplin","year":"2009","unstructured":"Poplin E, Feng Y, Berlin J, Rothenberg ML, Hochster H, Mitchell E, Alberts S, O\u2019Dwyer P, Haller D, Catalano P, Cella D, Benson AB (2009) Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the eastern cooperative oncology group. J Clin Oncol 27:3378\u20133785","journal-title":"J Clin Oncol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-015-2819-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-015-2819-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-015-2819-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T12:27:54Z","timestamp":1566995274000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-015-2819-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,21]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["2819"],"URL":"https:\/\/doi.org\/10.1007\/s00280-015-2819-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,21]]}}}